Impact of Valproate and Levetiracetam Exposure on GAERS Behavior During Pregnancy
-
Published:2023-09-01
Issue:3
Volume:29
Page:69-74
-
ISSN:2792-0550
-
Container-title:Archives Of Epilepsy
-
language:
-
Short-container-title:ArchEpilepsy
Author:
Yavuz MelisORCID,
Kantarcı Berk CanORCID,
Şanlı AhmetORCID,
Gavaş ŞeyhmusORCID,
Turgan Aşık Zehra NurORCID,
Koyuncuoğlu TürkanORCID,
Kasımay ÖzgürORCID,
Onat FilizORCID
Publisher
Galenos Yayinevi
Reference41 articles.
1. Marescaux C, Vergnes M. Genetic Absence Epilepsy in Rats from Strasbourg (GAERS). Ital J Neurol Sci. 1995;16(1):113-118. [CrossRef]
2. Danober L, Deransart C, Depaulis A, Vergnes M, Marescaux C. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog Neurobiol. 1998;55(1):27-57. [CrossRef]
3. Marescaux C, Vergnes M, Depaulis A. Genetic absence epilepsy in rats from Strasbourg--a review. J Neural Transm Suppl. 1992;35:37-69. [CrossRef]
4. Brigo F, Igwe SC. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev. 2017;2(2):Cd003032. [CrossRef]
5. Nolan D, Lester SG, Rau SM, Shellhaas RA. Clinical Use and Efficacy of Levetiracetam for Absence Epilepsies. J Child Neurol. 2019;34(2):94-98. [CrossRef]